caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912004045

Teresea Olson

PRACTICEGLENDIVE MEDICAL CENTER, INCSee all providers at this practice →
Physician AssistantGlendive, MTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Teresea Olson's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
GLENDIVE MEDICAL CENTER, INC41139
Steven Gard
Physician Assistant · White Sulphur Spings, MT
1116
City Of Glendive
Ambulance Service Provider · Glendive, MT
1117
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
65
Beneficiaries
—
Total drug cost
$608
Distinct drugs
5
Brand share
46.2%
Top prescribed drugs
Amoxicillin/Potassium Clav15 claims
Nitrofurantoin Monohyd/M-Cryst15 claims
Amoxicillin13 claims
Azithromycin11 claims
Cephalexin11 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
80.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.